4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cerenome, Inc. (CNSY) operates in the Biotechnology industry and is headquartered in Houston, United States with about 28 employees. Its market capitalization is roughly $21 million. In the fiscal year ended 2025-12-31, CNSY reported $0M in revenue and ($22M) in net income.
Cerenome, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.
Interactive charts & full statements → Open the CNSY valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($15M) | ($15M) | ($13M) | ($20M) | — |
| Net Income | ($22M) | ($13M) | ($13M) | ($20M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — | — |
| Operating Income (EBIT) | ($9M) | ($7M) | ($6M) | ($4M) | ($2M) | — | — |
| Net Income | ($9M) | ($7M) | ($6M) | ($4M) | $5M | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $16M | $7M | $11M | $24M | — |
| Total Liabilities | $12M | $16M | $13M | $17M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CNSY viewer.
About TickerBase · Data methodology & sources · Privacy · Terms